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Identification of ceramide targets in interleukin-1 and tumor
necrosis factor-a signaling in mesangial cells. An increasing
number of cell-surface receptors have been shown to trigger
sphingomyelin turnover and generation of the lipid signaling
molecule ceramide. Ceramide plays a role in mediating cellular
responses as diverse as inflammation, differentiation, gene expres-
sion, growth suppression, and apoptosis. A radioiodinated, pho-
toaffinity-labeling analog of ceramide ([125I]TID-ceramide) was
used to identify downstream signaling targets of ceramide. Cer-
amide was found to bind specifically to and activate protein kinase
c-Raf, leading to subsequent activation of the extracellular signal-
regulated kinase (ERK) module in mesangial cells. We found also
that ceramide binds to and differentially modulates the activity of
distinct protein kinase C isoenzymes. These data are discussed in
the context of interleukin 1b-induced inflammatory gene expres-
sion in mesangial cells.
Interleukin 1 (IL-1) is a major product of activated
monocytes and is also released by many cell types when
exposed to an inflammatory environment. The biological
activities of IL-1 are initiated by binding to two types of
IL-1 receptors, designated IL-1 receptors type I and type II.
Although the cytoplasmic portions of both IL-1 receptors
do not contain kinase domains or motifs homologous to any
other known signaling pathway, rapid intracellular protein
phosphorylation occurs in response to IL-1 stimulation.
The nature of the primary signal delivered by IL-1 receptor
activation is poorly understood and is controversial [1, 2],
but it is clear that IL-1 does stimulate protein kinase
activities in a wide variety of different cells. The tumor
necrosis factor (TNF) family includes TNFa and TNFb or
lymphotoxin that bind to two distinct but structurally
homologous receptors: the TNFR1 (p55) and the TNFR2
(p75). None of these receptors possess motifs implying
catalytic activity [3]. Both IL-1 and TNFa rapidly activate
mitogen-activated protein kinase (MAPK) in fibroblasts,
U937 cells, KB cells, and mesangial cells [2, 4, 5]. Further-
more, both cytokines employ the sphingomyelin signaling
pathway to generate ceramide and to stimulate a putative
ceramide-activated serine/threonine protein kinase [6–8].
THE SPHINGOMYELIN SIGNALING PATHWAY
The fundamental role of lipid-derived second messen-
gers in almost any known cell function is well established.
The prototypic signaling molecules derived from glycero-
phospholipids such as 1,2-diacylglycerol, inositol 1,4,5-
trisphosphate, phosphatidic acid, lysophosphatidic acid,
arachidonic acid, and platelet-activating factor have been
studied intensively over the last two decades. More re-
cently, the importance of another class of membrane
phospholipids—the sphingolipids—and signaling mole-
cules derived therefrom has been discovered and is now a
major focus of research in areas concerned with the
regulation of cell growth and differentiation, programmed
cell death, and inflammation [6–8].
Sphingolipids are derivatives of long-chain bases and
display a great structural diversity and complexity. As
shown in Figure 1, they have a headgroup at position 1 of
the ceramide backbone, such as phosphorylcholine, to form
sphingomyelin and carbohydrates to form glycosphingolip-
ids. Sphingomyelin is located predominantly in the outer
leaflet of the plasma membrane. Biosynthesis of sphingo-
lipids is shown in Figure 2 and starts with the condensation
of serine and palmitoyl-CoA to yield 3-ketosphinganine,
which is reduced further to sphinganine and converted to
dihydroceramide by the enzyme ceramide synthase. In the
next step, headgroups are added to form sphingomyelin
and glycosphingolipids. This occurs mainly in the Golgi
apparatus and, in some cases, in the plasma membrane.
Degradation of sphingolipids begins with the removal of
headgroups. In the case of sphingomyelin, phosphorylcho-
line is released by acidic, neutral, and Mg21-dependent
sphingomyelinases to yield ceramide. Indeed, ceramide is a
central metabolite in sphingolipid catabolism and is de-
graded to fatty acid and free long-chain bases by neutral or
acidic ceramidases. The sphingosine thus formed can be
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reacylated subsequently to ceramide, phosphorylated to
yield sphingosine-1-phosphate, or methylated. Several of
these intermediates (ceramide, sphingosine, and sphin-
gosine-1-phosphate) have potential roles as second messen-
gers with ceramide being the best characterized [6–8].
A number of cytokines, growth factors, and other extra-
cellular mediators employ the sphingomyelin signaling
pathway to generate ceramide (Table 1). The mechanisms
coupling the receptors of the ligands to activation of
sphingomyelinases are not understood. With respect to
immediate targets of ceramide, suggestions for several
ceramide-activated enzymes have been forwarded. These
include a 97-kDa proline-directed serine/threonine protein
kinase [9, 10], which recently has been suggested to be
identical to kinase suppressor of Ras [11], a ceramide-
activated protein phosphatase of the ocadaic acid-sensitive
PP2A subgroup of protein phosphatases [12, 13], protein
kinase C (PKC) z [14], and the protein kinase c-Raf [5].
Addition of ceramide to intact cells or the pharmacological
modulation of endogenous levels of ceramide alters the
activity of members of the MAPK cascades [5, 15–21], the
classic extracellular signal-regulated kinases (ERK) 1 and 2,
and the more recently discovered stress-activated protein
kinases of the SAPK/JNK subfamily or the p38/RK subfamily.
These parallel signaling pathways (Fig. 3) regulate such fun-
damental aspects of cell function as metabolism, secretion,
and gene expression [reviewed in 22]. The archetypal signaling
cascade includes ERK1 and ERK2 and responds primarily to
mitogenic stimulation via Ras. In contrast, the SAPK and p38
Fig. 1. Chemical structure of sphingomyelin.
Fig. 2. Biosynthetic and catabolic pathways of
sphingolipids.
Table 1. Agents known to trigger elevation of cellular ceramide levels
Inducers of apoptosis TNF-a
Fas ligand
Dexamethasone
Inducers of differentiation Vitamin D3
TNF-a
Nerve growth factor (NFG)
Damaging agents Chemotherapeutics
Brefeldin A
Ultraviolet light
Ionizing irradiation
Inflammatory cytokines IL-la, IL-1b
TNF-a
Interferon-g
Pfeilschifter and Huwiler: Ceramide targets in mesangial cells S-35
pathways respond to cellular stresses such as inflammatory
mediators, poisons, heat, and high-energy radiation. However,
there are cell-type–specific patterns of activation of the differ-
ent MAPK cascades by a given ligand, which determines the
cell-specific response to this stimulus. Despite intensive efforts
in recent years, identification of molecular targets of ceramide
action has proved difficult and so far indirect. It is, however,
clear that ceramide delivers signals into one or several cas-
cades of the MAPK families (Fig. 3) in a cell-type–specific
manner to regulate cell responses such as proliferation, apo-
ptosis, or gene expression and subsequent mediator synthesis.
IDENTIFICATION OF CERAMIDE TARGETS
To identify downstream signaling targets of ceramide, we
employed a radioiodinated, photoaffinity-labeling analog
of ceramide with high [125I]iodine-specific radioactivity
(. 2000 Ci/mmol): [125I]3-trifluoromethyl-3-(m-iodophe-
nyl) diazirine-ceramide (TID-ceramide). Upon irradiation
with light at around 350 nm, the diazirine is rapidly
photolyzed to generate a carbene capable of reacting with
the full range of functional groups occurring in biomol-
ecules [23, 24]. Incubation of intact mesangial cells with
[125I]TID-ceramide for five minutes followed by homoge-
nization and sequential immunoprecipitation of the differ-
ent members of the MAPK modules with specific poly-
clonal antibodies revealed selective labeling of protein
kinase c-Raf, which increased to 243% 6 37% (mean 6 SD,
N 5 4) on UV-induced labeling [5]. There was no labeling
of ERK1 or RK2 or of their upstream activator MAPK or
ERK kinase (MEK), MEK kinase, PKCz, or any protein
immunoprecipitated with an antiphosphotyrosine antibody.
All antibodies used are known to immunoprecipitate their
Fig. 3. Potential ceramide targets in the different MAPK modules. Abbreviations are: MAPK, mitogen-activated protein kinase; ERK, extracellular
signal-regulated kinase; MEK, MAPK or ERK kinase; Tpl2, tumor progression locus 2; NIK, NFkB-inducing kinase; PAK, p21-activated protein kinase;
MEKK, MEK kinase; SAPK, stress-activated protein kinase; SEK, SAPK kinase; ASK-1, apoptosis signal-regulating kinase 1; MLK-3, mixed lineage
kinase 3; DLK, dual leucine zipper-bearing kinase; TAK1, TGFb-activated kinase 1; RK, reactivating kinase; RKK, RK kinase; PKC, protein kinase C.
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respective antigens [5, 25, 26]. Labeling by [125I]TID-ceramide
was inhibited by exogenous addition of increasing concentra-
tions of unlabeled ceramide (Fig. 4) by endogenous ceramide
produced by IL-1b prestimulation of the cells (Fig. 4). These
data establish that IL-1b–induced ceramide specifically binds
to c-Raf in mesangial cells. Comparable data were obtained
for TNFa-stimulated mesangial cells.
Next we investigated whether ceramide binding to c-Raf
also has functional consequences. Figure 5 shows that C6 and
C16 analogs of ceramide concentration-dependently in-
creased protein kinase c-Raf activity in an immunocomplex
kinase assay in vitro. Moreover, C6 and C16 analogs also
activated protein kinase c-Raf (evaluated using an immu-
nocomplex kinase assay) in vivo when added to intact cells.
Ceramide not only activated c-Raf, but the signal was
further processed along the MEK/ERK cascade and caused
an increased activity of ERK1 and ERK2 that could be
inhibited by PD 098059, a synthetic inhibitor of MEK [27].
To prove that IL-1b indeed uses this signaling pathway to
activate c-Raf in mesangial cells, we examined c-Raf phos-
phorylation and activity. IL-1b rapidly phosphorylates and
activates c-Raf within five minutes and subsequently stim-
ulates ERK activity [4, 5].
The serine/threonine kinase c-Raf is a well-studied sig-
naling device that is responsible for phosphorylation and
activation of MEK in the classic MAPK cascade [28]. The
mechanism of activation of protein kinase c-Raf has been
studied extensively, and it is now clear that this is a
multistep event. In the first step, c-Raf translocates to the
plasma membrane and associates with Ras-GTP. This
association with Ras-GTP is not sufficient for c-Raf activa-
tion but is required for its recruitment to the plasma
membrane [28]. In the next step, c-Raf is activated by an
unknown mechanism that may comprise tyrosine and/or
serine/threonine phosphorylation of c-Raf [28] or the in-
teraction with another membrane cofactor such as a lipid
[28, 29]. The c-Raf amino terminus contains a highly
conserved region (CR-1) that encompasses a zinc-finger
motif analogous to the lipid-binding domain of PKC, and it
is tempting to speculate that c-Raf is activated by the
binding of a lipid second messenger in a manner similar to
the mechanism of activation of PKC by 1,2-diacylglycerol.
These data clearly demonstrate that ceramide specifically
binds to c-Raf and stimulates its kinase activity. These
observations extend previous reports on putative lipid
factors extractable with chloroform/methanol from mem-
branes of activated cells that markedly enhance c-Raf
enzymatic activity [28, 30] and identify ceramide as a
lipid second messenger that acts as a major direct
activator of c-Raf in IL-1b- and TNFa-triggered signal
propagation.
Recently, Yao et al have reported that a 97-kDa ceram-
ide-activated protein kinase phosphorylates c-Raf on Thr-
269 and increases its activity toward MEK [16]. Further-
more, in intact HL-60 cells, ceramide-activated protein
kinase forms complexes with c-Raf and, in response to
TNFa, phosphorylates and activates c-Raf. In IL-1b-stim-
ulated mesangial cells, ceramide definitely does not bind to
a protein in the range of 97 kDa in the cell homogenates. In
contrast, our data define c-Raf itself as a ceramide-acti-
vated protein kinase, thus suggesting that there is more
than one ceramide-activated protein kinase and that cer-
amide may have cell-type–specific targets.
Another unexpected finding was that PKCz was not
labeled with TID-ceramide in mesangial cells. This obser-
vation contrasts with a report by Muller et al [14] who have
shown that ceramide and arachidonic acid compete for
binding to PKCz in a cell-free system. This again suggests
that ceramide may interact with potential targets in a
cell-type–specific manner. To clarify this issue further, we
investigated [125I]TID-ceramide binding to the complete
set of PKC isoenzymes expressed in mesangial cells, that is,
Fig. 4. Specific binding of [125I]TID-ceramide to c-Raf in vivo. Exogenous
ceramide and interleukin (IL)-1b pretreatment of mesangial cells de-
crease [125I]TID-ceramide binding to c-Raf. Mesangial cells were stimu-
lated for five minutes with 50 nM [125I]TID-ceramide (0.2 mCi/ml) and
directly lysed (lane 2) or photolyzed before lysis (lanes 1 and 3 to 6).
Binding of [125I]TID-ceramide was inhibited by addition of 450 nM (lane
4) or 50 nM (lane 5) exogenous unlabeled ceramide or by pretreatment of
the cells with 1 nM of IL-1b for two minutes before TID-ceramide addition
(lane 6). Thereafter, c-Raf was immunoprecipitated (lanes 2 to 6; lane 1,
preimmune serum), subjected to SDS/PAGE, and exposed to Hyperfilm
MP at 270°C. Reprinted from [5] with permission.
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PKCa, PKCd, PKCe, and PKCz [26, 31, 32]. Incubation of
mesangial cells with [125I]TID-ceramide and subsequent
immunoprecipitation of PKC isoenzymes defines PKCa
and PKCd as direct targets of ceramide. No binding of
ceramide to PKCe and PKCz could be detected. In vitro
kinase activity assays using purified recombinant PKC
isoenzymes show that only the binding of ceramide to
PKCa is accompanied by an increase in kinase activity
toward the generally used substrates histone IIIS and
a-pseudosubstrate peptide. In vivo activation of PKCa by
ceramide was monitored by delayed translocation of the
isoform from the cytosol to the membrane fraction of
mesangial cells. In contrast, neither PKCd, PKCe, or PKCz
are redistributed by ceramide (Andrea Huwiler and Josef
Pfeilschifter, unpublished observations).
PERSPECTIVES
Renal mesangial cells are a well-defined IL-1- and
TNFa–responsive cell type involved in most pathological
processes of the renal glomerulus [33, 34]. Resting mesan-
gial cells do not produce any inflammatory mediator con-
stitutively but require triggering by invading immune cells.
Three prominent features of mesangial cells evolve as a
result of the cross-talk with invading neutrophils and
monocytes: increased mediator production, increased ma-
trix synthesis, and increased mesangial cell proliferation. In
mesangial cells, IL-1 and TNFa reportedly induce the
expression of a specific type-IV collagenase, a group-II
phospholipase A2, eicosanoids, an inducible nitric oxide
synthase, and a variety of chemokines [34]. We have used
rat mesangial cells as a model system to evaluate IL-1- and
TNFa-triggered signaling events and find that inflamma-
tory cytokines stimulate ceramide production, which sub-
sequently specifically binds to and activates protein kinases
c-Raf and PKCa.
Two important aspects of this report are the identifica-
tion of ceramide as the long-missing lipid activator of c-Raf
and the identification of PKCa and c-Raf as additional, yet
molecularly defined, members of a growing family of
ceramide-activated protein kinases. Activation of c-Raf and
PKCa by ceramide is only one possible means of activating
these two kinases, especially in response to cytokine stim-
ulation.
Some immediate questions arising that we are currently
addressing are concerned with the molecular mechanism of
ceramide binding to target proteins. It will be an exciting
task to unveil a putative common binding motif for cer-
amide recruitment to c-Raf, PKCa and PKCd. Moreover,
we are currently investigating the possibility that ceramide
also signals to other members of the MAPK modules like
SAPK/JNK or p38/RK.
Fig. 5. Stimulation of c-Raf activity by C6-ceramide (M) and C16-ceramide () in vitro. c-Raf was immunoprecipitated from quiescent mesangial cells.
Immunoprecipitates were incubated in vitro for 15 minutes at 30°C with the indicated concentrations of C6 and C16 ceramide before the addition of
100 ng of recombinant MEKk- and 1 mCi of [g-32P]ATP for 10 minutes. Samples were subjected to SDS/PAGE, exposed to Hyperfilm MP, and
quantitated on a PhosphorImager. Data are expressed as percentage of the respective control values and are means of three independent experiments.
Inset: autoradiograph of one representative experiment. Reprinted from [5] with permission from the Proceedings of the National Academy of Sciences,
USA.
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